Imagine reaching for your daily medication, only to realize it’s not what you think it is—a mix-up that could put your health at serious risk. That’s the alarming reality for some Canadians right now, as Health Canada issues a critical warning about a medication recall that’s anything but routine. Here’s the full story, and trust me, it’s one you’ll want to read carefully.
Posted February 7, 2026, 7:08 pm
1 min read
Health Canada is urging Canadians to double-check their medicine cabinets after a startling discovery: two lots of MAR-Amlodipine 5 mg tablets have been recalled due to a potentially dangerous mix-up. But here’s where it gets even more concerning—some bottles labeled as MAR-Amlodipine might actually contain midodrine 2.5 mg tablets, a medication designed for low blood pressure, not high blood pressure.
MAR-Amlodipine is typically prescribed to manage high blood pressure and chest pain, but midodrine serves the opposite purpose—treating low blood pressure. And this is the part most people miss: taking the wrong medication could lead to severe health complications, including dangerously high blood pressure, dizziness, fainting, slow heartbeats, and even potential organ damage. Children, in particular, may face heightened risks if they accidentally take the incorrect medication.
The affected product details are as follows: MAR-Amlodipine 5 mg, DIN 02371715, from lots 2472021 and 2472021A, with an expiry date of July 2027. To identify the correct tablets, look for white to off-white, flat, eight-sided pills with a line across the middle. One side is marked “210” and “5,” while the other side is blank. The incorrect midodrine tablets, on the other hand, are white, round, and marked with “M2” on one side.
Health Canada is urging patients to act now: check your bottles immediately. If you find any round tablets or are unsure about the contents, return the bottle to your pharmacy without delay. Here’s the controversial question: How could such a critical mix-up occur in the first place? While Marcan Pharmaceuticals Inc. investigates, it’s a reminder of the fragility of our healthcare systems and the need for rigorous quality control.
Patients are advised to avoid taking the round tablets altogether. If you experience symptoms like dizziness, unusually high blood pressure, or slow heartbeats, don’t hesitate—contact a healthcare professional or call 911. Immediate medical attention is also recommended for chest pain, sudden headaches, trouble speaking, or numbness and weakness.
Health Canada is closely monitoring the recall and the company’s investigation, promising to notify the public if additional risks emerge. Consumers with questions can reach out directly to Marcan Pharmaceuticals Inc., and healthcare professionals are urged to inspect bottles carefully before dispensing and report any issues.
But here’s the bigger question: Could this happen again? And what steps are being taken to prevent similar mix-ups in the future? Let us know your thoughts in the comments below—this is a conversation that deserves your voice.
Stay informed and stay safe. For weekly health updates, subscribe to receive the latest medical news and health information delivered to your inbox every Sunday.
Trending Now
- Mark McMorris crash overshadows Canada’s opening curling win at Olympics Read More
- Israel team, JD Vance booed at Olympics opening ceremony Read More
© 2026 Global News, a division of Corus Entertainment Inc.
